Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
In this week’s Pathways Picks: CMS trims procedure payments in the name of efficiency, reimburses ADHD digital therapeutics, and approves real-world renal denervation study; FDA looks to cardio and AI advisory panels; China revamps and harmonizes GMP standards; India finalizes Class A device exemptions; South Korea invests in device innovation; EU forms new combo product group; and more.
AcuityMD has an AI-enabled sales platform designed specifically for the medical device industry. It helps sales leadership and reps target customers, while streamlining and speeding up the process of closing sales.
The American Medical Association launches digital health and AI center. Excerpted from Pathways’ Picks October 22: Tariff Pushback, “MAHA Pathway,” Docs' AI Plans, and More.